The association of four genetic variants with myelosuppression in gemcitabine‐treated Japanese is not evident in gemcitabine/carboplatin‐treated Swedes

Gemcitabine/carboplatin‐induced myelosuppressive adverse drug reactions (ADRs) are clinical problems leading to patient suffering and dose alterations. There is a need for personalised medicine to improve treatment effects and patients' well‐being. We tested four genetic variants, rs11141915, r...

Descripción completa

Detalles Bibliográficos
Autores principales: Björn, Niclas, Jakobsen, Ingrid, Udagawa, Chihiro, Brandén, Eva, Koyi, Hirsh, Lewensohn, Rolf, De Petris, Luigi, Zembutsu, Hitoshi, Gréen, Henrik
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2022
Materias:
Clinical Pharmacology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9303231/
https://www.ncbi.nlm.nih.gov/pubmed/35132780
http://dx.doi.org/10.1111/bcpt.13712

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9303231/
https://www.ncbi.nlm.nih.gov/pubmed/35132780
http://dx.doi.org/10.1111/bcpt.13712

Ejemplares similares